TrialDiabetes & metabolism journal2023

The Efficacy and Safety of Moderate-Intensity Rosuvastatin with Ezetimibe versus High-Intensity Rosuvastatin in High Atherosclerotic Cardiovascular Disease Risk Patients with Type 2 Diabetes Mellitus: A Randomized, Multicenter, Open, Parallel, Phase 4 Study.

Jun Sung Moon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.